Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 4/Signature 1
From BugSigDB
< Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection | Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 4
Source: Figure 6B
Description: LEfSe analysis results at the genus level between the DHT-induced PCOS mouse model and the control (CTL) group.
Abundance in Group 1: increased abundance in Polycystic Ovary Syndrome (PCOS) group
Revision editor(s): Victoria
